work, Ipamorelin released GH with potency comparable to the older peptide GHRP-6 but, unlike GHRP-6 and GHRP-2, did not meaningfully elevate adrenocorticotropic hormone (ACTH), cortisol, or prolactin even at doses well above the GH-releasing threshold
The treatment is generally well-tolerated, with manageable side effects, and is administered via once-weekly subcutaneous injections, promoting patient adherence and consistent usage
The glucagon receptor activation increases energy expenditure through thermogenesis and enhances fat oxidation
Ozempic is FDA-approved for type 2 diabetes at doses up to 2 mg
These considerations have potential to account for the important observation that the LASSS-pretreatment displayed greater preventive effect on nitration of Y198 compared to Y250 (Figure 2b)
Your doctor will look at your whole health picture, not test results alone